Iatrogenic cardiac perforation due to pacing lead displacement: Imaging findings.

PURPOSE: Cardiac perforations due to pacing and implantable defibrillator lead displacement are rare and their detection may be difficult. The goal of this study was to review the clinical and imaging presentation of cardiac perforation related to pacing lead displacement. PATIENTS AND METHODS: The clinical and imaging files of four patients (two men and two women) who experienced cardiac perforation related to pacing lead displacement were reviewed. The four patients were investigated in our radiology department over a 24-month-period. RESULTS: Two patients had clinical symptoms at the time lead displacement was detected and the other two were free of symptoms. In all patients, lead displacement was visible on imaging examinations in retrospect but was not detected prospectively. CONCLUSION: Radiologists should pay attention to the position of the tips of the leads on chest X-ray and CT, even late after the implantation and in asymptomatic patients.

Assessment of left ventricular mass and volumes by three-dimensional echocardiography in patients with or without wall motion abnormalities: comparison against cine magnetic resonance imaging.

AIM: To evaluate if three-dimensional echocardiography (3-DE) is as accurate and reproducible as cine magnetic resonance imaging (cMR) in estimating left ventricular (LV) parameters in patients with and without wall motion abnormalities (WMA). METHODS: 83 patients (33 with WMA) underwent 3-DE and cMR. 3-DE datasets were analysed using a semi-automatic contour detection algorithm. The accuracy of 3-DE was tested against cMR in the two groups of patients. All measurements were made twice by two different observers. RESULTS: LV mass by 3-DE was similar to that obtained by cMR (149 (SD 42) g vs 148 (45) g, p = 0.67), with small bias (1 (28) g) and excellent interobserver agreement (-2 (31) g vs 4 (26) g). The two measurements were also highly correlated (r = 0.94), irrespective of WMA. End-diastolic and end-systolic LV volumes and ejection fraction by 3-DE and cMR were highly correlated (r = 0.97, 0.98, 0.94, respectively). Yet, 3-DE underestimated cMR end-diastolic volumes (167 (68) ml vs 187 (70) ml, p<0.001) and end-systolic volumes (88 (56) ml vs 101 (65) ml, p<0.001), but yielded similar ejection fractions (50% (14%) vs 50% (16%), p = 0.23). CONCLUSION: 3-DE permits accurate determination of LV mass and volumes irrespective of the presence or absence of WMA. LV parameters obtained by 3-DE are also as reproducible as those obtained by cMR. This suggests that 3-DE can be used to follow up patients with LV hypertrophy and/or remodelling.